BRUSSELS, Sept 10 (Reuters) - Teva (TEVA.TA), the world's largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a rival product to its blockbuster
Dec 29 (Reuters) - A U.S. judge ruled in favor of Israel's Teva Pharmaceutical Industries (TEVA.TA) in a patent infringement lawsuit brought by Corcept Therapeutics (CORT.O), sparking a frenzied
Nov 24 (Reuters) - Israel-based drugmaker Teva Pharmaceuticals (TEVA.TA) has agreed to end a patent lawsuit over Eli Lilly's (LLY.N) migraine drug Emgality following a U.S. Patent Office decision
BRUSSELS, Oct 31 (Reuters) - Teva (TEVA.TA) the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to
We previously reported that on January 11, 2018, Celltrion, Inc., Celltrion Healthcare, Co. Ltd. (collectively “Celltrion”), Teva Pharmaceuticals International GmbH, and Teva Pharmaceuticals USA
The US Supreme Court will today hear a patent dispute between Helsinn Healthcare and Teva Pharmaceuticals, with lawyers telling WIPR that the probable reversal in the case will have a wide-ranging
total 1 pages, 6 items